Pfizer to buy King Pharmaceuticals

Pfizer, the world’s largest drug company by revenues, has agreed to buy King Pharmaceuticals, a maker of prescription pain treatments, for $3.6bn in cash as it seeks to diversify its portfolio before it loses patent protection on key drugs.